Melissa A. Abt

Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.

Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1.